Skip to content

Anti-A, B Monoclonal

by Rapid Labs Ltd United Kingdom EUDAMED

Ref BG-AB10Model Monoclonal EMDN W0103030102

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-05060599400310GP Basic UDI-DIDate22 Apr 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/IVDD Expiring

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 22 Oct 2026

Model / Reference
Monoclonal, BG-AB10
Primary DI / UDI-DI
D-05060599400310GP, 5060599400310X5
Basic UDI-DI
B-05060599400310GP, B-5060599400310X5
EMDN Code
W0103030102 Abo sera
Device Class
Class IVD Annex II List A
Market of Registration
Poland
Greece

Manufacturer details

EUDAMED SRN
GB-MF-000026335
Authorised representative
Advena Limited MT-AR-000000234

Other devices from Rapid Labs Ltd

See all devices from Rapid Labs Ltd →

Properties & raw data

Show properties, registry sources and raw records
  • Animal Tissues
  • Reagent
  • Professional Testing
Other properties (7)
  • Sterile: No
  • Human Tissues: No
  • Microbial Substances: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No

Sources (2)

  • EUDAMED 361679d8-8a50-4b2e-83d8-65aaf9861745 61 fields · synced 22 Oct 2026
  • EUDAMED 5060599400310X5|B-5060599400310X5 61 fields · synced 9 Oct 2026